SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, FMBI, SWN, ENVB, MLND; Shareholders are Encouraged to Contact the Firm
NEW YORK, June 5, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to MorphoSys AG for $34.00 per share in cash. If you are a Constellation shareholder, click here to learn more about your rights and options.
First Midwest Bancorp, Inc. (NASDAQ: FMBI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Old National Bancorp. Under the terms of the merger agreement, First Midwest stockholders will receive 1.1336 shares of Old National common stock for each share of First Midwest common stock they own. Following completion of the transaction, former First Midwest stockholders are expected to own approximately 44% of the combined company. If you are a First Midwest shareholder, click here to learn more about your rights and options.
Southwestern Energy Company (NYSE: SWN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its acquisition of Indigo Natural Resources, LLC for approximately $2.7 billion. The merger consideration is comprised of cash, Southwestern Energy common stock, and the assumption of senior notes. If you are a Southwestern Energy shareholder, click here to learn more about your rights and options.
Enveric Biosciences, Inc. (NASDAQ: ENVB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with MagicMed Industries Inc. Upon completion of the transaction, current Enveric shareholders will own approximately 63.4% of the combined company's common stock, as calculated on a fully diluted basis. If you are an Enveric shareholder, click here to learn more about your rights and options.
Millendo Therapeutics, Inc. (NASDAQ: MLND) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Tempest Therapeutics, Inc. Upon completion of the merger, Millendo shareholders are expected to own approximately 18.5% of the combined company while pre-merger Tempest stockholders will own approximately 81.5% of the combined company. If you are a Millendo shareholder, click here to learn more about your rights and options.
Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llp-investigates-cnst-fmbi-swn-envb-mlnd-shareholders-are-encouraged-to-contact-the-firm-301306402.html
SOURCE Halper Sadeh LLP
